Cochrane Abstracts
Sulfadoxine‐pyrimethamine plus artesunate versus sulfadoxine‐pyrimethamine plus amodiaquine for treating uncomplicated malaria Unchanged
Sulfadoxine‐pyrimethamine plus artesunate versus sulfadoxine‐pyrimethamine plus amodiaquine for treating uncomplicated malaria Unchanged is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Sulfadoxine‐pyrimethamine Plus Artesunate Versus Sulfadoxine‐pyrimethamine Plus Amodiaquine for Treating Uncomplicated Malaria Unchanged." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434787/all/Tiagabine_add‐on_therapy_for_drug‐resistant_focal_epilepsy_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed 23 March 2023.
Sulfadoxine‐pyrimethamine plus artesunate versus sulfadoxine‐pyrimethamine plus amodiaquine for treating uncomplicated malaria Unchanged. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434787/all/Tiagabine_add‐on_therapy_for_drug‐resistant_focal_epilepsy_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed March 23, 2023.
Sulfadoxine‐pyrimethamine plus artesunate versus sulfadoxine‐pyrimethamine plus amodiaquine for treating uncomplicated malaria Unchanged. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434787/all/Tiagabine_add‐on_therapy_for_drug‐resistant_focal_epilepsy_New_search_for_studies_and_content_updated__no_change_to_conclusions_
Sulfadoxine‐pyrimethamine Plus Artesunate Versus Sulfadoxine‐pyrimethamine Plus Amodiaquine for Treating Uncomplicated Malaria Unchanged [Internet]. In: Cochrane Abstracts. [cited 2023 March 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434787/all/Tiagabine_add‐on_therapy_for_drug‐resistant_focal_epilepsy_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sulfadoxine‐pyrimethamine plus artesunate versus sulfadoxine‐pyrimethamine plus amodiaquine for treating uncomplicated malaria Unchanged
ID - 434787
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434787/all/Tiagabine_add‐on_therapy_for_drug‐resistant_focal_epilepsy_New_search_for_studies_and_content_updated__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
